Latest New Zealand News

Horizon Oil achieved record production and sales in FY26, driven by its Thailand assets, and completed the off-market takeover of Cue Energy, expanding its footprint across five countries.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.

Microba Life Sciences has wrapped up a $5.41 million capital raise combining a $5 million institutional Placement and a $407,500 Share Purchase Plan, strengthening its balance sheet to accelerate growth in Australia and the UK.

Talius Group maintained steady revenue in Q2 2026, boosted by $2 million in new aged care contracts and a 10% increase in active subscriptions.

Siren Gold's mining permit application for Sams Creek was declined, yet the company reports strong exploration progress at Queen Charlotte and Langdons projects, positioning for future drilling.

Develop Global (ASX:DVP) posted a record June quarter with Woodlawn copper-zinc production up 47%, supported by a US$400 million Trafigura financing deal that underpins its Sulphur Springs and Pioneer Dome projects.

EVZ Limited closed FY26 with a net positive operating cash flow of $10.1 million and an $18.3 million cash balance, while maintaining a robust $80 million contract backlog and progressing several acquisition opportunities for FY27.

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.

Sena & Co, already holding 75.9% of 2 Cheap Cars, proposes a full takeover at NZ$0.80 per share, aiming to delist the company and compulsorily acquire remaining shares.

The Calmer Co International Ltd is raising up to $3.5 million through a 1-for-1 renounceable entitlement offer priced at $0.001 per share, including free attaching options exercisable at $0.002. The capital will fund debt repayment, inventory expansion, marketing, and product launches.

Lotus Resources has secured A$34.2 million from institutional investors in a fully underwritten entitlement offer, with a retail component set to raise an additional A$26 million. The funds aim to support the Kayelekera uranium project’s production ramp-up and financial stability.

Minerals Exploration Limited has completed its first phase of diamond drilling at the historic Jubilee Gold Mine within the Waitekauri Gold Project, confirming multiple quartz-mineralised zones and exceptional high-grade rock chip assays. Exploration continues with promising results at the Invincible Gold and Glenorchy Tungsten projects.